China Universal Asset Management Co. Ltd. boosted its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 417.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,546 shares of the biopharmaceutical company’s stock after buying an additional […]